KENNETH I. KAITIN

Business address
C/O Tufts Cntr For The Study Of Drug Dev, 75 Kneeland St, Suite 1100, Boston, MA, 02111
Top holdings (ownership)
CRIS
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
KENNETH I. KAITIN has filed 34 SEC EDGAR filings since 16 Apr 2004

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 22 May 2025 20 May 2025 000-30347
4 Open Document Open Filing FORM 4 30 Jan 2025 28 Jan 2025 000-30347
4 Open Document Open Filing FORM 4 23 May 2024 21 May 2024 000-30347
4 Open Document Open Filing FORM 4 24 Jan 2023 23 Jan 2023 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 31 Jan 2022 31 Jan 2022 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 29 Jan 2021 28 Jan 2021 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 04 Mar 2020 02 Mar 2020 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 25 Jan 2019 23 Jan 2019 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 23 Jan 2019 21 Jan 2019 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 24 Jan 2018 22 Jan 2018 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 02 Jun 2017 31 May 2017 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2017 28 Feb 2017 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 27 May 2016 26 May 2016 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jan 2016 19 Jan 2016 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION 28 Jan 2015 26 Jan 2015 000-30347
4 Open Document Open Filing 2014 ANNUAL GRANT 28 Jan 2014 27 Jan 2014 000-30347
4 Open Document Open Filing 2013 ANNUAL GRANT 18 Jan 2013 17 Jan 2013 000-30347
4 Open Document Open Filing 2012 ANNUAL GRANT 06 Jan 2012 05 Jan 2012 000-30347